News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Adrian Lee: Altered estrogen disposition and immune signals in the TME of breast cancers in older women
Adrian Lee/LinkedIn
Nov 6, 2024, 11:20

Adrian Lee: Altered estrogen disposition and immune signals in the TME of breast cancers in older women

Adrian Lee, Professor at UPMC Hillman Cancer Center, shared on X:

“Out on bioRxiv our study by Neil Carleton and the Lee-Oesterreich lab/collaborators on altered estrogen disposition and immune/inflammatory signals in the TME of breast cancers in older women.”

Adrian Lee

Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women.

Authors: Neil Carleton, Sanghoon Lee, Ruxuan Li, Jian Zou, Daniel D Brown, Jagmohan Hooda, Alexander Chang, Rahul Kumar, Linda R Klei, Lora H Rigatti, Joseph Newsome, Dixcy Jaba Sheeba John Mary, Jennifer M Atkinson, Raymond E West III, Thomas D Nolin, Patrick J Oberly, Ziyu Huang, Donald Poirier, Emilia J Diego, Peter C Lucas, George Tseng, Michael T Lotze, Priscilla F McAuliffe, Ioannis K Zervantonakis, Steffi Oesterreich, Adrian V Lee

Adrian Lee

Adrian Lee Adrian V Lee Alexander Chang bioRxiv cancer Daniel D Brown Dixcy Jaba Sheeba John Mary Donald Poirier Emilia J Diego estrogen disposition George Tseng Ioannis K Zervantonakis Jagmohan Hooda Jennifer M Atkinson Jian Zou Joseph Newsome Lee-Oesterreich lab Linda R Klei Lora H Rigatti Michael T Lotze Neil Carleton OncoDaily Oncology Patrick J Oberly Peter C. Lucas Priscilla F McAuliffe Rahul Kumar Raymond E West III Ruxuan Li Sanghoon Lee Steffi Oesterreich Thomas D Nolin Ziyu Huang
Special Coverage
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer
Blog
Nov 13, 2024, 08:39
Eva Blondeaux on safety of pregnancy in BRCA carriers